Since its creation CEA has been involved in biology and health research and has become a recognised player in technological innovations and their integration. It can thus legitimately position itself as a major player in the field.
FOREWORD
INNOVATION AND THE HEALTH SYSTEM
By Ms Agnès Buzyn, French Minister for Solidarity and Health
VIEWPOINT
DO ADVANCES IN BIOTECHNOLOGIES ALWAYS MEAN PROGRESS FOR THE PATIENTS? AN ETHICAL QUESTION
By Prof. Jean-François Delfraissy, Chairman of the National Consultative Committee on Ethics for the life and health sciences (CCNE)
CONTEXT
WHAT WILL THE MEDICINE OF TOMORROW LOOK LIKE?
By Prof. François Sigaux, Executive Scientific Director for Fundamental Research (DRF) at CEA
I CHALLENGES FOR HEALTH
Building on its electronics and digital expertise and its life sciences skills, CEA is heavily engaged in addressing the major health challenges.
- BIOMEDICAL IMAGING
- NEUROSCIENCES
- MEDICAL GENETICS
- INFECTIOLOGY
- GENE THERAPY
- CANCEROLOGY
- VISION DISORDERS
- METABOLIC DISEASES
II TECHNOLOGIES FOR MEDICINE
In collaboration with the other players in the field, CEA is working on offering health professionals rapid diagnosis tools, innovative therapies and efficient decision-making aids.
- INTRODUCTION
- BIOLOGICAL COMPANIONS
- MULTI-DISCIPLINARY TECHNOLOGICAL TOOLS
- HEALTH DATA SECURITY
III OUTLOOK
AN ALLIANCE FOR THE MEDICINE OF THE FUTURE
IV AFTERWORD
At the DIGITAL/INNOVATION CROSSROADS
By François Jacq, CEA Chairman